Ali Raza Khaki (Stanford)
95% of new oncology drugs approved in US before Europe in past decade, study finds
Ali Raza Khaki is a bladder cancer doctor at Stanford. He’s seen five immune checkpoint inhibitors approved as a second line of treatment, but he …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
